Evidence map›Paper›PMID 38643546›Full record

ArticleEpidemics2024

Characterising information gains and losses when collecting multiple epidemic model outputs.

Katharine Sherratt, Ajitesh Srivastava, Kylie Ainslie, David E Singh, Aymar Cublier, Maria Cristina Marinescu, Jesus Carretero, Alberto Cascajo Garcia, Nicolas Franco, Lander Willem and 19 more

Abstract read
In one paragraph

Article in Epidemics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Katharine SherrattLondon School of Hygiene & Tropical Medicine, London, UK. Electronic address: katharine.sherratt@lshtm.ac.uk.
Ajitesh SrivastavaUniversity of Southern California, Los Angeles, USA.
Kylie AinslieDutch National Institute of Public Health and the Environment (RIVM), Bilthoven, Netherlands; School of Public Health, University of Hong Kong, Hong Kong Special Administrative Region.
David E SinghUniversidad Carlos III de Madrid, Madrid, Spain.
Aymar CublierUniversidad Carlos III de Madrid, Madrid, Spain.
Maria Cristina MarinescuBarcelona Supercomputing Center, Barcelona, Spain.
Jesus CarreteroUniversidad Carlos III de Madrid, Madrid, Spain.
Alberto Cascajo GarciaUniversidad Carlos III de Madrid, Madrid, Spain.
Nicolas FrancoUniversity of Namur, Namur, Belgium.
Lander WillemUniversity of Antwerp, Antwerp, Belgium.
Steven AbramsUniversity of Antwerp, Antwerp, Belgium; UHasselt, Hasselt, Belgium.
Christel FaesUHasselt, Hasselt, Belgium.
Philippe BeutelsUniversity of Antwerp, Antwerp, Belgium.
Niel HensUniversity of Antwerp, Antwerp, Belgium; UHasselt, Hasselt, Belgium.
Sebastian MüllerTechnische Universität Berlin, Berlin, Germany.
Billy CharltonTechnische Universität Berlin, Berlin, Germany.
Ricardo EwertTechnische Universität Berlin, Berlin, Germany.
Sydney PaltraTechnische Universität Berlin, Berlin, Germany.
Christian RakowTechnische Universität Berlin, Berlin, Germany.
Jakob RehmannTechnische Universität Berlin, Berlin, Germany.
Tim ConradZuse Institute Berlin (ZIB), Berlin, Germany.
Christof SchütteZuse Institute Berlin (ZIB), Berlin, Germany.
Kai NagelTechnische Universität Berlin, Berlin, Germany.
Sam AbbottLondon School of Hygiene & Tropical Medicine, London, UK.
Rok GrahECDC, Stockholm, Sweden.
Rene NiehusECDC, Stockholm, Sweden.
Bastian PrasseECDC, Stockholm, Sweden.
Frank SandmannECDC, Stockholm, Sweden.
Sebastian FunkLondon School of Hygiene & Tropical Medicine, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCollaborative comparisons and combinations of epidemic models are used as policy-relevant evidence during epidemic outbreaks. In the process of collecting multiple model projections, such collaborations may gain or lose relevant information. Typically, modellers contribute a probabilistic summary at each time-step. We compared this to directly collecting simulated trajectories. We aimed to explore information on key epidemic quantities; ensemble uncertainty; and performance against data, investigating potential to continuously gain information from a single cross-sectional collection of model results.

methodsWe compared projections from the European COVID-19 Scenario Modelling Hub. Five teams modelled incidence in Belgium, the Netherlands, and Spain. We compared July 2022 projections by incidence, peaks, and cumulative totals. We created a probabilistic ensemble drawn from all trajectories, and compared to ensembles from a median across each model's quantiles, or a linear opinion pool. We measured the predictive accuracy of individual trajectories against observations, using this in a weighted ensemble. We repeated this sequentially against increasing weeks of observed data. We evaluated these ensembles to reflect performance with varying observed data.

resultsBy collecting modelled trajectories, we showed policy-relevant epidemic characteristics. Trajectories contained a right-skewed distribution well represented by an ensemble of trajectories or a linear opinion pool, but not models' quantile intervals. Ensembles weighted by performance typically retained the range of plausible incidence over time, and in some cases narrowed this by excluding some epidemic shapes.

conclusionsWe observed several information gains from collecting modelled trajectories rather than quantile distributions, including potential for continuously updated information from a single model collection. The value of information gains and losses may vary with each collaborative effort's aims, depending on the needs of projection users. Understanding the differing information potential of methods to collect model projections can support the accuracy, sustainability, and communication of collaborative infectious disease modelling efforts.

Indexed as

COVID-19SARS-CoV-2BelgiumEpidemicsEpidemiological ModelsHumansIncidenceModels, StatisticalNetherlandsSpainAggregationInformationModellingScenariosUncertainty

Identifiers

PMID38643546
PMCPMC11196924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.